Spots Global Cancer Trial Database for Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Official Title: Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Study ID: NCT02203136

Conditions

Bladder Cancer

Interventions

Tissue Biopsy

Magnetic Resonance Imaging (MRI)

Study Description

Brief Summary: The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.

Detailed Description: If participant agrees to take part in the study, a piece of the tumor that is removed during the biopsy will be collected for research purposes. The tissue will be sent to the laboratory for genetic testing. If they have had a computed tomography scan (CT scan) or magnetic resonance imaging scan (MRI) recently, information collected from the scan will be collected. If they have not had one recently, they will have an MRI with contrast as part of this study. They will receive a separate consent form for this MRI scan. The results of the test will be given to their doctor, but the results will not be used to decide their treatment. After they have surgery, information will be collected from their medical records, such as their diagnosis. Length of Study: * Their participation on this study will be over once their surgery is completed. * This is an investigational study. Up to 100 participants will take part in this study. All will be enrolled at MD Anderson.